ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

NCI Adds $700,000 to CCOP Budget, Makes Four New Awards

June 9, 1989

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

June 7, 2013

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007